Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturers:
|
Amoxil
Amoxicillin sodium 250mg
Powder for injection
GlaxoSmithKline (NZ) Limited
SmithKline Beecham Pharmaceuticals Limited, West Sussex, United Kingdom
Biopharma SrL, Rome, Italy
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturers:
|
Amoxil
Amoxicillin sodium 500mg
Powder for injection
GlaxoSmithKline (NZ) Limited
SmithKline Beecham Pharmaceuticals Limited, West Sussex, United Kingdom
Biopharma SrL, Rome, Italy
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturers:
|
Amoxil
Amoxicillin sodium 1g
Powder for injection
GlaxoSmithKline (NZ) Limited
SmithKline Beecham Pharmaceuticals Limited, West Sussex, United Kingdom
Biopharma SrL, Rome, Italy
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Milrinone-Claris
Milrinone lactate 1.43mg/mL equivalent to Milrinone 1mg/mL
Concentrate for injection
AFT Pharmaceuticals Limited
Claris Injectables Limited, Gujarat, India
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Pentasa
Mesalazine 4g
Modified release granules
Pharmaco (NZ) Limited
Ferring International Center SA, St-Prex, Switzerland
|
Dated this 6th day of November 2015.
DEREK FITZGERALD, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
Gazette.govt.nz